SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corporation

Applied Digital is experiencing intense volatility as investors weigh the stock's long-term potential in the data center and AI infrastructure sector against macro-driven sell-offs linked to geopolitical tensions and debt concerns. While the community remains divided between those panic-selling and those adding to their positions ahead of upcoming earnings, sentiment is heavily focused on the anticipation of new hyperscaler lease announcements that could serve as a major catalyst for a price recovery.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant volatility as investors weigh the company's shift toward high-performance AI data center infrastructure against macro-driven sell-offs and geopolitical instability in the Middle East. While community sentiment remains polarized, many participants are focused on the company's execution timeline for new site energization and the potential for major hyperscaler contract announcements to serve as a catalyst for recovery.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is facing intense community debate as investors weigh concerns over potential dilution and future stock splits against optimism surrounding the commercial traction and insurance coverage expansion of their lead product, Tonmya. While some shareholders are selling amid downward price pressure and a history of capital raises, others are aggressively buying the dip, citing strong long-term pipeline fundamentals and recent insider share purchases as evidence of an impending turnaround.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is seeing heightened market attention as traders closely monitor the expected finalization of a multi-billion dollar debt financing deal, which is widely viewed as a critical catalyst for the firm's data center expansion. The stock's recent volatility has sparked intense debate among community members, who are actively balancing concerns over insider selling and high debt levels against the company's strategic partnerships and potential upside in the evolving AI infrastructure sector.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently rallying as investors position the stock as a primary 'bring-your-own-power' solution for the surging AI data center buildout, further fueled by recent policy discussions surrounding energy infrastructure independence. The community is actively debating the stock's valuation and volatility, while tracking technical breakout levels and watching for institutional accumulation as the company solidifies its role in the critical power generation sector.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing intense volatility as investors debate the impact of its newly announced five-for-one stock split, with many in the community viewing the move as a tactic to boost retail liquidity and obscure ongoing concerns regarding subprime loan exposure. The stock remains a battleground for traders, with heavy debate over potential technical breakdowns versus institutional efforts to defend key price levels.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is capturing significant market attention following positive long-term Phase 3 VELA data, with investors increasingly focused on the stock's potential as a best-in-class candidate in the competitive immunology space. While some retail shareholders express frustration over recent volatility and perceived market manipulation, community sentiment remains largely driven by anticipation of upcoming 52-week data readouts and persistent speculation regarding a potential buyout from major biopharma players.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae ($FNMA) is seeing intense trading activity as investors react to ongoing speculation about an exit from conservatorship, with prominent figures like Bill Ackman and Michael Burry reportedly maintaining long positions. Community sentiment remains deeply divided, with bulls pointing to potential future catalysts and institutional buying, while bears emphasize the lack of concrete news and the stock's recent volatility.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy is capturing significant market attention following its recent NASDAQ debut and business combination, as traders speculate on the potential for massive oil reserves in the Jameson Land Basin. The community is actively debating the company's long-term exploration goals versus short-term volatility, with many monitoring volume, potential squeezes, and the involvement of experienced industry leadership.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductors are currently the subject of intense debate as the sector balances extreme investor enthusiasm for AI-driven infrastructure against mounting fears of a parabolic bubble and cyclical overextension. Market participants are actively weighing record project backlogs and bullish sentiment against rising concerns regarding long-term ROI, high capital expenditure, and the potential for a sharp mean reversion that could pressure broader market indices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company said its NOOR Collagen supplement is projected to generate over $12 million in annualized revenue.</li><li>Cosmos said the impact on operations due to the Middle East conflict is negligible.</li><li>The firm is in the process of acquiring a Greece-based pharmacy distribution network.</li></ul>Cosmos Health Inc (COSM) drew retail attention on Thursday after the company said it is exploring potential capital-raising options, including monetizing non-core assets, to address what it described as a “valuation disconnect”.The company said its shares are currently trading well below book value, adding that its market capitalization does not fully reflect the strength of its operations or the value of its diversified asset base. Management said it may use proceeds to support strategic investments, acquisitions, and possible share buybacks.<a href="https://stocktwits.com/symbol/COSM">COSM shares</a> were up around 3% at $0.3. The company has a price-to-book ratio of 0.67 compared to the industry average of 4.48, according to Investing.com.<h2 class="st-heading-2">Cosmos’ Sky Premium Life Brand To Generate 75% Gross Margin</h2>Cosmos Health expects gross margins of around 75% and strong cash flow from its U.S. operations for the Sky Premium Life brand. Sky Premium sells nutraceuticals, vitamins, and food supplements. The company said its NOOR Collagen supplement alone is projected to generate over $12 million in annualized revenue.The company stated it is actively advancing its acquisition strategy, highlighted by a recent letter of intent to acquire a Greece-based pharmacy distribution network generating approximately $11.5 million in annual revenue. The move supports the company’s broader plan to scale operations and achieve its 2027 revenue target of $155.8 million.Cosmos Health also said that the recent global geopolitical conflict has had a negligible impact on its operations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘bullish’ from ‘neutral’ a day earlier, but chatter was mixed. One user expects a 90% to 95% increase in the stock’s price from its record lows of $0.28.<stembedurl>https://stocktwits.com/Letsgetpd/message/648003039</stembedurl>Another user said the stock has plenty of room to continue falling.<stembedurl>https://stocktwits.com/Stopcryin/message/647973933</stembedurl>The stock has been under selling pressure so far this year, with shares down around 35%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/humacyte-secures-saudi-order-why-did-huma-stock-crash-to-record-low/cZ3ao9nRIhh">Humacyte Secures $1.5M Saudi Order – Why Did HUMA Stock Crash To Record Low Today?</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart on black background. | Image source: Getty Images

This Nano Cap Pharmaceutical Company Flags ‘Valuation Disconnect’ –  But Retail Sees Upto 95% Upside From Record Lows

Cosmos Health expects gross margins of around 75% and strong cash flow from the U.S. operations of its Sky Premium Life brand

COSM Stock In Spotlight As Company Explores Raising Capital To Address ‘Valuation Disconnect’  

Equity

Grigorios Siokas Acquires 388,532 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 388,532 shares of the stock in a transaction dated Thursday, February 12th. The shares were bought at an average cost...

Cosmos Health (NASDAQ:COSM) CEO Buys $119,417.42 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 291,262 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was acquired at an...

Cosmos Health (NASDAQ:COSM) CEO Purchases $176,660.50 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 353,321 shares of Cosmos Health stock in a transaction on Tuesday, January 20th. The shares were bought at an average...

Grigorios Siokas Buys 493,495 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 493,495 shares of the firm's stock in a transaction on Wednesday, January 14th. The shares were acquired at an...

Cosmos Health (NASDAQ:COSM) CEO Acquires $43,273.86 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 88,314 shares of the stock in a transaction dated Friday, December 19th. The shares were purchased at an average cost of...

Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Acquires 168,472 Shares

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 168,472 shares of the business's stock in a transaction that occurred on Monday, December 15th. The shares were bought...

Grigorios Siokas Purchases 76,360 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 76,360 shares of the business's stock in a transaction dated Friday, November 28th. The stock was acquired at an...

Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Buys $35,111.16 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 55,732 shares of the stock in a transaction that occurred on Tuesday, November 25th. The shares were bought at an...

Grigorios Siokas Buys 51,315 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 51,315 shares of Cosmos Health stock in a transaction on Thursday, November 20th. The stock was bought at an average...

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Cosmos Health Inc

Fred Wilson - Union Square Ventures

Abigail Johnson - Fidelity

Jim Cramer - Media Personality

Josh Brown - Ritholtz Wealth Management

A lifetime achievement for industry titans. This honor is reserved for an individual whose groundbreaking contributions have shaped the investing landscape and how we engage with the markets.

Current Price	$0.32
Prev Close	$0.3249
Open	$0.32
Dividend Yield	0.00%
50-Day Moving Average	$0.4071
Beta	1.35
Avg. Volume	744,487.03
PE Ratio	-0.46

52-Week High	$1.32
52-Week Low	$0.2801
Market Capitalization	$12.16M
EPS (Annual)	-$1.17
Price to Book	0.45
Revenue Per Employee	$365,277.87

COSM
Cosmos Health Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COSM News

COSMCosmos Health Inc.